CHROMOSOME ABNORMALITIES IN SPONTANEOUS ABORTIONS: APPLICATION OF MULTICOLOR FLUORESCENT IN SITU HYBRIDIZATION AND ORIGINAL DNA PROBES FOR CHROMOSOMES 1, 9, 13, 14, 16, 18, 21, 22, X AND Y
Vorsanova SG1,*, Kirilova EA2, Yurov YB3, Kolotii AD1, Monakhov VV3, Iourov IY3, Beresheva AK1
*Corresponding Author: : Professor Dr. Svetlana G. Vorsanova, Director of Molecular-Cytogenetic Laboratory of Neuropsychiatric Diseases, Institute of Pediatrics and Children Surgery, Russian Ministry of Health, TaldomŽskaya str 2, 127 412 Moscow, Russia; Tel.: +7-095-484-1948; Fax: +7-095-952-8940; E-mail: y_yurov@ yahoo.com
page: 49

DISCUSSION

The main aim of this study was prospective interphase FISH diagnosis of chromosomal anomalies in spontaneous abortion specimens. We used a probe set for chromosomes 1, 9, 13, 14, 16, 18, 21, 22, X, and Y, as it well known that aneuploidies involving these chromosomes are most frequent in humans [1,2,8,9]. The results obtained allowed us to explain the cause of fetus losses in 55% of the speci­mens analyzed. The presence of chromosomal aneuploi­dies involving other chromosomes (2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 15, 17, 19, 20) cannot be excluded as we have not tested for these by FISH in the present study. In recent studies, chromosome 2, 7, 10, 15, and 17 are also recog­nized as being involved in spontaneous abortions [3,8]. Therefore, the frequency of chromosomal abnormalities in these specimens could be higher. The set of DNA probes used is highly informative for aneuploidy screening in spontaneous abortion specimens. Recently, Jobanputra et al. [8], using interphase FISH with a probe set for chromo­somes 13, 15, 16, 18, 21, 22, X and Y, have identified 54% of chromosomal abnormalities in spontaneous abor­tion specimens, which is similar to data obtained in the present study.

Fluorescent in situ hybridization that allows the study of aneuploidies in a large number of interphase cells could be considered as an efficient method for analysis of chro­mosomal mosaicism. Accurate scoring of a large number of interphase nuclei using two- or three-color FISH per­formed in our study, allowed us to identify mosaic forms of aneuploidies and polyploidy in 20 (51.3%) specimens with chromosomal abnormalities. Therefore, postzygotic non disjunction of chromosomes could take place in fe­tuses during the first trimester of pregnancy with a higher frequency than has been detected before using karyotyping techniques.

There are several reports about an excess of normal female karyotypes over normal male karyotypes in sponta­neous abortion specimens [7,8]. In the present study we detected 24 normal female and four normal male karyo­types among the 63 specimens analyzed. A prevalence of female fetuses (male/female ratio 15/48) was also detected among all the specimens studied. One can propose that contamination by maternal cells could occur during speci­men processing for FISH. Alternatively, the dramatic loss of male fetuses with chromosome abnormalities or lethal X-linked gene mutations, can take place in earlier stages of pregnancy thus leading to such a prevalence of female fetuses. The future direction of the study is to clarify the real cause of non random sex ratios.

The set of original DNA probes was found to be appli­cable for accurate and rapid screening of aneuploidies in spontaneous abortion specimens, allowing the determina­tion of regular as well as mosaic forms of chromosome abnormalities.

Figure 1. Examples of interphase mFISH in cells of spontaneous abortions using: A) a Cy3-labeled DNA probe for chromosomes 13/21 (four red signals) and a biotin-labeled DNA probe for chromosome 9 (five green signals) in samples with pentasomy 9; B) a Cy3-labeled DNA probe for chromosomes 13/21 (six red signals) and a biotin-labeled DNA probe for chromosome 9 (three green signals) in samples with triploidies.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006